ArticleBlood cancer journal2017
Assessing the effect of obesity-related traits on multiple myeloma using a Mendelian randomisation approach.
Abstract readLetter
In one paragraph
Article in Blood cancer journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- GWAS-Identified Variants for Obesity Do Not Influence the Risk of Developing Multiple Myeloma: A Population-Based Study and Meta-Analysis.International journal of molecular sciences · 2023Pooled it
- Systematic review of Mendelian randomization studies on risk of cancer.BMC medicine · 2022Pooled it
- Causal relationships between body composition and hematological malignancies: a multivariable mendelian randomization analysis.Cancer causes & control : CCC · 2025Article
- Cancer and Obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022.Obesity pillars · 2022Article
- The Role of Mendelian Randomization Studies in Deciphering the Effect of Obesity on Cancer.Journal of the National Cancer Institute · 2022Article
- Epidemiology, genetics and treatment of multiple myeloma and precursor diseases.International journal of cancer · 2021Review
- Adiposity and cancer: a Mendelian randomization analysis in the UK biobank.International journal of obesity (2005) · 2021Article
- Metabolic Disorders in Multiple Myeloma.International journal of molecular sciences · 2021Review
- Search for multiple myeloma risk factors using Mendelian randomization.Blood advances · 2020Article
- Exposing the Causal Effect of Body Mass Index on the Risk of Type 2 Diabetes Mellitus: A Mendelian Randomization Study.Frontiers in genetics · 2019Article
- Waist circumference and risk of 23 site-specific cancers: a population-based cohort study of Korean adults.British journal of cancer · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
36 authors.
M WentDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
A SudDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
P J LawDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
D C JohnsonDivision of Molecular Pathology, The Institute of Cancer Research, London, UK.
N WeinholdMyeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
A FörstiMolecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany.
M van DuinDepartment of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
J S MitchellDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
B ChenMolecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany.
R KuiperDepartment of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
O W StephensMyeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
U BertschDepartment of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.
C CampoMolecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany.
H EinseleDepartment of Internal Medicine II, Division of Hematology and Medical Oncology, University Hospital Würzburg, Würzburg, Germany.
W M GregoryClinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
M HenrionDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
J HillengassDepartment of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.
P HoffmannInstitute of Human Genetics, University of Bonn, Bonn, Germany.
G H JacksonRoyal Victoria Infirmary, Newcastle upon Tyne, Newcastle, UK.
O LeniveDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
J NickelDepartment of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.
M M NöthenInstitute of Human Genetics, University of Bonn, Bonn, Germany.
M I da Silva FilhoMolecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany.
H ThomsenMolecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany.
B A WalkerMyeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
A BroylDepartment of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
F E DaviesMyeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
C LangerDepartment of Internal Medicine III, University of Ulm, Ulm, Germany.
M HanssonDivision of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Lund, Sweden.
M KaiserDivision of Molecular Pathology, The Institute of Cancer Research, London, UK.
P SonneveldDepartment of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
H GoldschmidtDepartment of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.
K HemminkiMolecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany.
B NilssonDivision of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Lund, Sweden.
G J MorganMyeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
R S HoulstonDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Funding
Tumor Cell-Microenvironment Interactions in the Molecular Pathogenesis of MultiplP01CA055819 · NCI · UNIV OF ARKANSAS FOR MED SCIS · PI VAN RHEE, FRITS · 1993 to 2013
$49.7MCancer Research UK C1298/A8362Medical Research Council G0100132NCI NIH HHS P01 CA055819Wellcome Trust
Abstract
PubMed holds no abstract for this paper.
Indexed as
Genome-Wide Association StudyMendelian Randomization AnalysisQuantitative Trait LociFemaleHumansMaleMultiple MyelomaObesity
Identifiers
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.